210 related articles for article (PubMed ID: 32201027)
1. Immune-mediated inflammatory polyneuropathy overlapping Charcot-Marie-Tooth 1B.
Escorcio-Bezerra ML; Pinto WBVR; Bichuetti DB; Souza PVS; Nunes RM; Silva LHL; Lima KDF; Manzano GM; Oliveira ASB; Baeta AM
J Clin Neurosci; 2020 May; 75():228-231. PubMed ID: 32201027
[TBL] [Abstract][Full Text] [Related]
2. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.
Sanmaneechai O; Feely S; Scherer SS; Herrmann DN; Burns J; Muntoni F; Li J; Siskind CE; Day JW; Laura M; Sumner CJ; Lloyd TE; Ramchandren S; Shy RR; Grider T; Bacon C; Finkel RS; Yum SW; Moroni I; Piscosquito G; Pareyson D; Reilly MM; Shy ME;
Brain; 2015 Nov; 138(Pt 11):3180-92. PubMed ID: 26310628
[TBL] [Abstract][Full Text] [Related]
4. Charcot-Marie-Tooth 1B caused by expansion of a familial myelin protein zero (MPZ) gene duplication.
Speevak MD; Farrell SA
Eur J Med Genet; 2013 Oct; 56(10):566-9. PubMed ID: 23811036
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of Charcot-Marie-Tooth disease due to myelin protein zero: An electrodiagnostic, nerve ultrasound and histological study.
Fabrizi GM; Tamburin S; Cavallaro T; Cabrini I; Ferrarini M; Taioli F; Magrinelli F; Zanette G
Clin Neurophysiol; 2018 Jan; 129(1):21-32. PubMed ID: 29136549
[TBL] [Abstract][Full Text] [Related]
6. Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B.
Sabet A; Li J; Ghandour K; Pu Q; Wu X; Kamholz J; Shy ME; Cambi F
Neurology; 2006 Oct; 67(7):1141-6. PubMed ID: 17030746
[TBL] [Abstract][Full Text] [Related]
7. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
8. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease.
Roa BB; Warner LE; Garcia CA; Russo D; Lovelace R; Chance PF; Lupski JR
Hum Mutat; 1996; 7(1):36-45. PubMed ID: 8664899
[TBL] [Abstract][Full Text] [Related]
9. CIDP, CMT1B, or CMT1B plus CIDP?
Cardellini D; Zanette G; Taioli F; Bertolasi L; Ferrari S; Cavallaro T; Fabrizi GM
Neurol Sci; 2021 Mar; 42(3):1127-1130. PubMed ID: 33070202
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the Myelin Protein Zero result in a spectrum of Charcot-Marie-Tooth phenotypes.
Kochański A
Acta Myol; 2004 May; 23(1):6-9. PubMed ID: 15298082
[TBL] [Abstract][Full Text] [Related]
11. A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies.
Iida M; Koike H; Ando T; Sugiura M; Yamamoto M; Tanaka F; Sobue G
Neuromuscul Disord; 2012 Feb; 22(2):166-9. PubMed ID: 21940171
[TBL] [Abstract][Full Text] [Related]
12. Genetic and clinical spectrums in Korean Charcot-Marie-Tooth disease patients with myelin protein zero mutations.
Kim HJ; Nam SH; Kwon HM; Lim SO; Park JH; Kim HS; Kim SB; Lee KS; Lee JE; Choi BO; Chung KW
Mol Genet Genomic Med; 2021 Jun; 9(6):e1678. PubMed ID: 33825325
[TBL] [Abstract][Full Text] [Related]
13. Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain.
Laurà M; Milani M; Morbin M; Moggio M; Ripolone M; Jann S; Scaioli V; Taroni F; Pareyson D
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1263-6. PubMed ID: 17940173
[TBL] [Abstract][Full Text] [Related]
14. Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT).
Gharesouran J; Hosseinzadeh H; Naghiloo A; Ghafouri-Fard S; Hussen BM; Taheri M; Rezazadeh M; Samadian M
Metab Brain Dis; 2023 Aug; 38(6):1963-1970. PubMed ID: 36952089
[TBL] [Abstract][Full Text] [Related]
15. Severe demyelinating hypertrophic polyneuropathy caused by a de novo frameshift mutation within the intracellular domain of myelin protein zero (MPZ/P0).
Zschüntzsch J; Dibaj P; Pilgram S; Kötting J; Gerding WM; Neusch C
J Neurol Sci; 2009 Jun; 281(1-2):113-5. PubMed ID: 19344920
[TBL] [Abstract][Full Text] [Related]
16. Myelin protein zero gene dose dependent axonal ion-channel dysfunction in a family with Charcot-Marie-Tooth disease.
Moldovan M; Pisciotta C; Pareyson D; Krarup C
Clin Neurophysiol; 2020 Oct; 131(10):2440-2451. PubMed ID: 32829291
[TBL] [Abstract][Full Text] [Related]
17. Novel mutation in the
Kozina AA; Baryshnikova NV; Ilinskaya AY; Kim AA; Plotnikov NA; Pogodina NA; Surkova EI; Shatalov PA; Ilinsky VV
J Int Med Res; 2022 Dec; 50(12):3000605221139718. PubMed ID: 36567457
[TBL] [Abstract][Full Text] [Related]
18. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
[TBL] [Abstract][Full Text] [Related]
19. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic clustering in MPZ mutations.
Shy ME; Jáni A; Krajewski K; Grandis M; Lewis RA; Li J; Shy RR; Balsamo J; Lilien J; Garbern JY; Kamholz J
Brain; 2004 Feb; 127(Pt 2):371-84. PubMed ID: 14711881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
